We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 192

Guide for Distributors of Medical Devices - A "Must Read" For All Distributors
  • William Fry
  • Ireland
  • March 16 2018

In February 2018, the Health Products Regulation Authority (HPRA) published a comprehensive guide in relation to the obligations of distributors of

The Irish Health Products Regulatory Authority Vows to Protect the Availability of Medicines to Irish Patients Post-Brexit
  • Arthur Cox
  • United Kingdom, European Union, Ireland
  • July 31 2017

The HPRA has recently announced its firm commitment to protect the availability of medicinal products for Irish patients and the integrity of the

HPRA publishes draft Medical Device Distributor Guidance for open consultation
  • Arthur Cox
  • Ireland
  • April 11 2017

11-04-2017 On 4 April 2017, the Health Products Regulatory Authority (“HPRA”) published for consultation a draft guide to distribution of medical

Review of Irish Merger Control in 2016
  • A&L Goodbody
  • Ireland
  • January 6 2017

This is a review of the transactions notified to the Competition and Consumer Protection Commission (CCPC) in 2016 and an analysis of Irish merger

Regulatory Enforcement Power of Ireland’s Health Products Regulatory Authority
  • A&L Goodbody
  • Ireland
  • October 25 2016

HPRA regularly carries out announced and unannounced inspections (Dawn Raids) and audits to establish and monitor industry’s compliance with relevant

Clinical trial agreements: Five key concepts
  • LK Shields
  • Ireland
  • January 24 2013

Clinical trials play a pivotal role in the development of market-safe pharmaceuticals and medical devices and, needless to say, sit within an

Bribery and corruption - a renewed focus
  • Matheson
  • United Kingdom, Ireland
  • July 4 2011

Friday, 1 July 2011, saw the long-anticipated UK Bribery Act 2010 coming into force

Disclosure in Irish patent proceedings
  • Matheson
  • Ireland
  • May 16 2011

The discovery (or disclosure) stage of patent proceedings can be a key strategic element yet burdensome part of the litigation

Commission consults on EU transparency rules in relation to pricing and reimbursement of medicines
  • Matheson
  • European Union, Ireland
  • May 2 2011

European Member States are responsible for their own health insurance schemes and for determining the pricing for medicines and their reimbursement status

MRSA rates decreasing claim HSE
  • Matheson
  • Ireland
  • April 12 2010

Against a backdrop of controversy, standards and guidelines, in May 2009 the Health Information and Quality Authority ("HIQA") published their National Standards for the Prevention and Control of Health Care Associated Infections ("Standards"